Cocaine-induced pseudovasculitis

Mayo Clinic Proceedings

Volumn 80, Issue 5, 2005, Pages 671-673

  Friedman, Daphne R ^a   Wolfsthal, Susan D ^a  

^a UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; COCAINE; NARCOTIC AGENT; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; ENDOSCOPY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; LEUKOCYTOCLASTIC VASCULITIS; PHYSICAL EXAMINATION; PSEUDO VASCULITIS; SEROLOGY; SKIN BIOPSY; SKIN ULCER; TRANSTHORACIC ECHOCARDIOGRAPHY; VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 18244389678     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/80.5.671     Document Type: Article

References (13)

1. Grau R. Pseudovasculitis: mechanisms of vascular injury and clinical spectrum. Curr Rheumatol Rep. 2002;4:83-89.
2. Sack KE. Mimickers of vasculitis. In: Koopman WJ, ed. Arthritis and Allied Conditions: A Textbook of Rheumatology. Vol 2. 14th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2001:1711-1735.
3. Chevalier X, Rostoker G, Larget-Piet B, Gherardi R. Schoenlein-Henoch purpura with necrotizing vasculitis after cocaine snorting [letter]. Clin Nephrol. 1995;43:348-349.
4. Heng MC, Haberfeld G. Thrombotic phenomena associated with intravenous cocaine. J Am Acad Dermatol. 1987;16(2, pt 2):462-468.
5. Hofbauer GF, Burg G, Nestle FO. Cocaine-related Stevens-Johnson syndrome. Dermatology. 2000;201:258-260.
6. Hofbauer GF, Hafner J, Trueb RM. Urticarial vasculitis following cocaine use [letter]. Br J Dermatol. 1999;141:600-601.
7. Orriols R, Munoz X, Ferrer J, Huget P, Morell F. Cocaine-induced Churg-Strauss vasculitis. Eur Respir J. 1996;9:175-177.
8. Tomecki KJ, Wikas SM. Cocaine-related bullous disease [letter]. J Am Acad Dermatol. 1985;12:585-586.
9. Trimarchi M, Gregorini G, Facchetti F, et al. Cocaine-induced midline destructive lesions: clinical, radiographic, histopathologic, and serologic features and their differentiation from Wegener granulomatosis. Medicine (Baltimore). 2001;80:391-404.
10. McLaren JS, Stimson RH, McRorie ER, Coia JE, Luqmani RA. The diagnostic value of anti-neutrophil cytoplasmic antibody testing in a routine clinical setting. QJM. 2001;94:615-621.
11. Russell KA, Wiegert E, Schroeder DR, Homburger HA, Specks U. Detection of anti-neutrophil cytoplasmic antibodies under actual clinical testing conditions. Clin Immunol. 2002;103:196-203.
12. Schmitt WH, van der Woude FJ. Clinical applications of antineutrophil cytoplasmic antibody testing. Curr Opm Rheumatol. 2004;16:9-17.
13. Daoud MS, Gibson LE, DeRemee RA, Specks U, el-Azhary RA, Su WP. Cutaneous Wegener's granulomatosis: clinical, histopathologic, and immunopathologic features of thirty patients. J Am Acad Dermatol. 1994;31:605-612.